brolucizumab new, stronger, longer acting anti vegf the current clinical evidence - dr. adrian koh
Published 2 years ago • 874 plays • Length 26:17Download video MP4
Download video MP3
Similar videos
-
1:48
post hoc keynote-040 analysis: pembrolizumab for hnscc produces lasting immune effect
-
2:59
doctors testing plasma as "immune therapy"
-
7:23
chapter 6 trials already happening around the world
-
1:01
the current landscape of antibody-based therapies in r/r dlbcl
-
1:20
immunologist explains how ‘supercharged’ cells help fight against covid-19
-
1:12
new issue alert: hematology special issue 2020
-
3:49
advances in technologies used to assess immune function in myeloma
-
14:39
focus on christof niehrs
-
2:45
first-in-kentucky technology investment transforms neuro care
-
8:09
#512 pre clinical evaluation of immune response to stem cell boosted degradable nanostructured surgi
-
10:05
proliferative retinopathy in hemoglobin c trait
-
36:15
advances in macular degeneration treatments
-
34:37
andre franke: genetic risk and protection in covid-19 disease
-
0:12
nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program...
-
25:42
correlates of protection for covid‐19: what we’ve learned so far
-
23:35
netwise special episode: covid-19 and nets: what you need to know
-
15:02
cipo2015: durable immune control of all requires a multi-antigen immune response